NCT04418973

Brief Summary

The dyspnea is a common symptom in patients with many respiratory diseases particularly chronic obstructive airway diseases, but also cardiovascular pathologies, obesity, or also in the deconditioned healthy subjects. Called volatolom corresponds to the set of volatile organic compounds (VOCs) contained in exhaled air. The analysis of volatolom can be done either by the methods based on mass spectrometry which allows the identification of each VOC in the exhaled air or by the use of electronic noses which are more simple to use, less specific and produce a quantitive signal change based on pattern recognition algorithms providing a global profile of the VOC without identifying them. The aim of the study is to determine whether the analysis of VOCs in exhaled air would identify biomarkers related to the intensity and type of experimental dyspnea.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2020

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 5, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

September 7, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 14, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 14, 2020

Completed
Last Updated

October 22, 2020

Status Verified

October 1, 2020

Enrollment Period

1 month

First QC Date

February 12, 2020

Last Update Submit

October 21, 2020

Conditions

Keywords

VolatolomVolatile organic compounds (VOCs)dyspneaelectronic nosemass spectrometry

Outcome Measures

Primary Outcomes (1)

  • Comparison of variation of volatile organic compounds profiles in exhaled air during dyspnea and normal breathing.

    Comparison of variation in VOC profiles in exhaled air of healthy subjects, over 2 types of dyspnea (inspiratory load and breath holding) relative to VOC profiles during normal rest ventilation. The VOC will be identified by their molecular mass (by the mass spectrometry) and the variations in the sensors properties of the electronic noses producing a quantitive signal change based on pattern recognition algorithms.

    at the only one study visit: around 2 hours

Secondary Outcomes (4)

  • Comparison of variation of volatile organic compounds profiles in exhaled air between the 2 types of dyspnea.

    at the only one study visit: around 2 hours

  • Correlation between the intensity of the affective component of the dyspnea and the variation of VOC profiles.

    at the only one study visit: around 2 hours

  • Correlation between the intensity of the sensory components of the dyspnea and the variation of VOC profiles.

    at the only one study visit: around 2 hours

  • Comparison of VOC profiles in exhaled air according to smoking status.

    at the only one study visit: around 2 hours

Study Arms (2)

A - load/apnea

EXPERIMENTAL

Threshold inspiratory load then apnea

Other: VOCs analysis in exhaled air

B- apnea/load

EXPERIMENTAL

apnea than threshold inspiratory load

Other: VOCs analysis in exhaled air

Interventions

using an electronic nose and a mass spectrometry

A - load/apneaB- apnea/load

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • healthy subject
  • no dyspnea
  • non smoking or daily smoking more than 5 years packs
  • perfect knowing of the French language
  • the consent form signed
  • affiliated to a health insurance plan

You may not qualify if:

  • chronic disease
  • history of asthma or Chronic obstructive pulmonary disease (COPD)
  • personal or family atopy
  • cannabis use
  • electronic cigarette
  • medication except contraception
  • pregnant woman
  • without liberty or guardianship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Foch hospital

Suresnes, 92151, France

Location

MeSH Terms

Conditions

Dyspnea

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Philippe Devillier

    Hopital Foch

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2020

First Posted

June 5, 2020

Study Start

September 7, 2020

Primary Completion

October 14, 2020

Study Completion

October 14, 2020

Last Updated

October 22, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations